(Q58468264)

English

Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate

article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

based on heuristic

inferred from title

attention deficit hyperactivity disorder

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Carlos Treceño

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Maria Sáinz

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Inés Salado

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Pilar García Ortega

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Veronica Velasco

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Antonio Escudero

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Alfonso Velasco

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Alfonso Carvajal

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Luis H Martín Arias

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

17 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Pharmacoepidemiology and Drug Safety

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

435-441

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Trends in the prescribing of psychotropic medications to preschoolers

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

National trends in the treatment of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Trends in medication treatment for ADHD.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Prevalence and patterns of methylphenidate use in French children and adolescents

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Australian national trends in stimulant dispensing: 2002-2009.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Medicine goes to school: teachers as sickness brokers for ADHD

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Is ADHD a valid diagnosis in adults? Yes.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Is ADHD a valid diagnosis in adults? No.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Euphorigenic and abusive properties of modafinil

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

ADHD drugs and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Nonmedical use of prescription stimulants in the United States

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

The nonmedical use of prescription ADHD medications: results from a national Internet panel

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Sudden death and use of stimulant medications in youths.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Spotlight on atomoxetine in attention-deficit hyperactivity disorder in children and adolescents

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Stimulant treatment for children: a community perspective.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2348

21 January 2018

Identifiers

10.1002/PDS.2348

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22253017%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58468264&oldid=1833395873"